09:53 AM EDT, 09/11/2025 (MT Newswires) -- Lucid Diagnostics ( LUCD ) said Thursday it closed an underwritten public offering of around 28.8 million common shares, including about 3.8 million shares issued under the full exercise of the overallotment option.

The company said it expects total net proceeds to be around $26.9 million, which its intends to use for working capital and general corporate purposes.

Price: 1.03, Change: +0.01, Percent Change: +0.98